Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adial Pharmaceuticals, Inc.

NASDAQ: AZR · Life Sciences · 8 alerts · CIK 1513525

Share price
$3.81Close, Nov 16
Market cap
$54.4M
Shares outstanding
14.29MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adial Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:15 PM ET 8-K
Shareholder Meeting

Adial Pharmaceuticals Shareholder Meeting

Adial Pharmaceuticals has further adjourned its 2026 Annual Meeting of Stockholders with respect to Proposals 3, 4, 5, and 6 until October 26, 2026. The delay is intended to provide additional time to obtain Nasdaq's conditional approval of an Initial Listing Application related to those specific proposals.

4:16 PM ET 8-K
Shareholder Meeting

Adial Pharmaceuticals Shareholder Meeting

Adial Pharmaceuticals has further adjourned its 2026 Annual Meeting of Stockholders with respect to Proposals 3, 4, 5, and 6 until October 15, 2026. The delay is intended to provide additional time to obtain Nasdaq's approval of an Initial Listing Application related to those specific proposals. Votes already cast on these proposals remain valid, and the record date remains August 17, 2026.

4:28 PM ET 8-K
Shareholder Meeting

Adial Pharmaceuticals Shareholder Meeting

Adial Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 17, 2026, where shareholders elected two Class II directors and approved several equity-related proposals. Key approvals included an amendment to the 2017 Equity Incentive Plan, the adoption of the new 2026 Equity Incentive Plan, and the 2026 Employee Stock Purchase Plan.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.